Trial Profile
Phase II trial of S-1 based therapy+/-Trastuzmab combination therapy for unresectable gastric cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Trastuzumab (Primary) ; Cisplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 29 Jul 2011 New trial record